According to our (Global Info Research) latest study, the global Gene Fragment market size was valued at US$ 371 million in 2025 and is forecast to a readjusted size of US$ 770 million by 2032 with a CAGR of 11.1% during review period.
Gene fragments are pieces of genes containing only the exons (those parts of the gene which actually encode the protein sequence). They are composed of cDNA. Gene Fragment can be used in CRISPR-Based Genome Editing, Recombinant Antibody Engineering, cloning process, qPCR and PCR Controls, Enzyme Engineering, Vaccine Research, High Resolution Melt (HRM) Assays etc field.
Global key players of gene fragment include Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, etc. The top five players hold a share over 70%. North America is the largest market, has a share about 40%, followed by Asia-Pacific, and Europe, with share 29% and 25%, separately.
This report is a detailed and comprehensive analysis for global Gene Fragment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gene Fragment market size and forecasts, in consumption value ($ Million), sales quantity (Million bp), and average selling prices (USD/bp), 2021-2032
Global Gene Fragment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Million bp), and average selling prices (USD/bp), 2021-2032
Global Gene Fragment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Million bp), and average selling prices (USD/bp), 2021-2032
Global Gene Fragment market shares of main players, shipments in revenue ($ Million), sales quantity (Million bp), and ASP (USD/bp), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Fragment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Fragment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, Twist Bioscience, Synbio Technologies, Bio Basic, BiOligo Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Gene Fragment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0-999 bp
1000-1999 bp
2000-3999 bp
4000+ bp
Market segment by Application
CRISPR-based Genome Editing
Antibody Engineering
Cloning Process
Others
Major players covered
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gene Fragment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gene Fragment, with price, sales quantity, revenue, and global market share of Gene Fragment from 2021 to 2026.
Chapter 3, the Gene Fragment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gene Fragment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Gene Fragment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gene Fragment.
Chapter 14 and 15, to describe Gene Fragment sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Gene Fragment. Industry analysis & Market Report on Gene Fragment is a syndicated market report, published as Global Gene Fragment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Gene Fragment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.